Unibest 优贝德
← Back to patent-cliff list

CAS 126-30-7

1,3-Dihydroxy-2,2-dimethylpropane2,2-dimethylpropane-1,3-diol

Codes:(XXXVIII)101438-55-d、IBUP-007、(II)90248-3-a

Application context (from source-drug indications)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate感冒布洛芬/盐酸去氧肾上腺素发热布洛芬/盐酸去氧肾上腺素头痛布洛芬/盐酸去氧肾上腺素避孕地诺孕素/戊酸雌二醇月经过多地诺孕素/戊酸雌二醇避孕行为地诺孕素/戊酸雌二醇盆腔疼痛地诺孕素/戊酸雌二醇头痛地诺孕素/戊酸雌二醇痛经地诺孕素/戊酸雌二醇入睡和睡眠障碍布洛芬/盐酸苯海拉明疼痛布洛芬/盐酸苯海拉明

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C — Watch / trade-
布洛芬/盐酸去氧肾上腺素Ibuprofen/Phenylephrine HydrochlorideTier C — Watch / trade-
地诺孕素/戊酸雌二醇Dienogest/Estradiol ValerateTier C — Watch / trade-
布洛芬/盐酸苯海拉明Ibuprofen/Diphenhydramine HydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.